The U.S. Food and Drug Administration (FDA) has published a presentation on ongoing activities of the FDA. It also intends to show how changes in FDA regulations and actions could affect pharmaceutical industry's practice. The following tasks are covered:

• FDA mission
• Approval and actions
• Drug safety information
• Safe Use Initiative
• REMS/Medication Guides
• Patient Medication Information (PMI)
• Sentinel Initiative
• OTC News
• Recalls
• Drug shortages
• Supply chain integrity

Get more in the presentation "FDA Update".

Related GMP News
22/05/2013	EMA issues Draft Guideline on Similar Biological Medicinal Products for public consultation
15/05/2013	GMP Guideline Manager Version 15.0 released
08/05/2013	Is there going to be "GMP Rating"?
29/04/2013	Brazil's GMP Guideline Available in English
17/04/2013	Written Confirmations: Time is running out - new EU Progress Report